Cat.#: ACPP-1204
| Despition | P2Y1 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1135 | ACTH Blocking Peptide (AC1135) | 250 µg | inquiry |
| ACPP-1468 | Human MEIS3 Protein (AC1468) | 5 µg | inquiry |
| ACPP-1572 | Human AIF1 Protein (AC1572) | 2 µg | inquiry |
| ACPP-1630 | Human ENO2 Protein, His (AC1630) | 2 µg | inquiry |
| ACPP-1327 | Dopamine Receptor D1 Blocking Peptide (AC1327) | 250 µg | inquiry |
| ACPP-1198 | PDE6 Alpha Blocking Peptide (AC1198) | 250 µg | inquiry |
| ACPP-1496 | Human SPINT2 Protein (AC1496) | 2 µg | inquiry |
| ACPP-1026 | Recombinant Human Neuropilin 1 Protein (6×His Tag) (AC1026) | 50 µg | inquiry |
| ACPP-1152 | PAX5 Blocking Peptide (AC1152) | 250 µg | inquiry |
| ACPP-1226 | PDE7A Blocking Peptide (AC1226) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.